banner
FXR inhibitor, PX20606 trans-isomer, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM313

FXR inhibitor, PX20606 trans-isomer, Purity ≥98%

Synonym: 1268244-85-4; PX-20606; PX 20606; PX-102; PX 102; PX10; 4-[(1R,2R)-2-[2-Chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid; FXR inhibitor

  • CAS Number: 1268244-85-4
  • Compound CID: 91754483
img
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
PX20606 trans-isomer is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting FXR. The molecular weight of the compound is 554.85, and its molecular formula is C29H22Cl3NO4.
Molecular Weight
554.85
Molecular Formula
C29H22Cl3NO4
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
PX20606 trans-isomer can be used for its ability to modulate bile acid synthesis and improve lipid metabolism.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0